Procter & Gamble Co. expands its US dietary supplement lineup with “nerve relief” products based on formulations it gained in its 2018 acquisition of Merck KGaAs consumer health business.
P&G is introducing its Nervive supplement line in the US after marketing the formulations under the brand Neurobion in Europe,...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?